HD group | non-HD group | p-value | Odds ratio | 95% CI | |
---|---|---|---|---|---|
Any complications within the time period | |||||
0–12 months | 13 (61.9) | 20 (28.2) | 0.0085 | 4.14 | 1.49–11.51 |
12–24 months | 7 (33.3) | 7 (9.9) | 0.0149 | 4.57 | 1.38–15.13 |
0–1 month | 10 (47.6) | 12 (16.9) | 0.0074 | 4.47 | 1.55–12.87 |
1–2 months | 2 (9.5) | 1 (1.4) | 0.1293 | 7.37 | 0.63–85.68 |
2–3 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
3–4 months | 2 (9.5) | 2 (2.8) | 0.2227 | 3.63 | 0.48–27.50 |
4–5 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
5–6 months | 2 (9.5) | 1 (1.4) | 0.1293 | 7.37 | 0.63–85.68 |
6–7 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
7–8 months | 1 (4.8) | 2 (2.8) | 0.5449 | 1.73 | 0.15–20.02 |
8–9 months | 1 (4.8) | 0 (0.0) | 0.2283 | N/A | N/A |
9–10 months | 1 (4.8) | 0 (0.0) | 0.2283 | N/A | N/A |
10–11 months | 1 (4.8) | 1 (1.4) | 0.4064 | 3.50 | 0.21–58.48 |
11–12 months | 2 (9.5) | 4 (5.6) | 0.6166 | 1.76 | 0.30–10.37 |
12–13 months | 1 (4.8) | 0 (0.0) | 0.2283 | N/A | N/A |
13–14 months | 0 (0.0) | 1 (1.4) | 1.0000 | N/A | N/A |
14–15 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
15–16 months | 0 (0.0) | 1 (1.4) | 1.0000 | N/A | N/A |
16–17 months | 0 (0.0) | 1 (1.4) | 1.0000 | N/A | N/A |
17–18 months | 2 (9.5) | 0 (0.0) | 0.0502 | N/A | N/A |
18–19 months | 1 (4.8) | 0 (0.0) | 0.2283 | N/A | N/A |
19–20 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
20–21 months | 0 (0.0) | 0 (0.0) | N/A | N/A | N/A |
21–22 months | 2 (9.5) | 2 (2.8) | 0.2227 | 3.63 | 0.48–27.50 |
22–23 months | 0 (0.0) | 1 (1.4) | 1.0000 | N/A | N/A |
23–24 months | 2 (9.5) | 2 (2.8) | 0.2227 | 3.63 | 0.48–27.50 |
0–24 months | 13 (61.9) | 25 (35.2) | 0.0429 | 2.99 | 1.09–8.18 |
Beyond two years | 12 (57.1) | 21 (29.6) | 0.0364 | 3.17 | 1.16–8.66 |